If you have been reading about Albumin binding and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-05-28. Where a claim depends on a specific study, the study is described rather than over-claimed.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
| Property | Value | Notes |
|---|---|---|
| Appearance as powder | White to off-white solid | Minor batch-to-batch variation is normal |
| Solubility class | Soluble in water and aqueous buffers | Dissolution can be slowed by aggregates |
| Typical storage temperature | Minus 20 degrees Celsius or below | Protected from light and moisture |
| Storage after reconstitution | 2 to 8 degrees Celsius, short term | Longer holding requires freezing |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity and identity confirmation |
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
== Further reading == Alexander, Mark, and John Sparry. Jump Commander: In Combat with the 82nd Airborne in World War II. Philadelphia: Casemate, 2010. ISBN 1-935149-28-8 OCLC 506253036 Angress, Werner T. Witness to the Storm: A Jewish Journey from Nazi Berlin to the 82nd Airborne, 1920–1945. Durham, NC: Miriam Angress, 2012. ISBN 1-4774-5701-1 OCLC 804824030 Anzuoni, Robert P. I'm the 82nd Airborne Division!: A History of the All American Division in World War II After Action Reports. Atglen, PA : Schiffer Publishing, 2005. ISBN 0-7643-2347-4 OCLC 62555533 Anzuoni, Robert P. The All American: An Illustrated History of the 82nd Airborne Division, 1917 to the Present. Atglen, PA: Schiffer Pub, 2001. ISBN 0-7643-1321-5 OCLC 49935879 Barry, Robert F. Power Pack: The Dominican Republic, 1965–1966. Portsmouth, Va: Messenger, 1965. OCLC 6655474 Baugh, James Emory. From Skies of Blue: My Experiences with the Eighty-Second Airborne During World War II. New York: iUniverse, 2003. ISBN 0-595-74982-8 OCLC 64584040 Breuer, William B. Drop Zone, Sicily: Allied Airborne Strike, July 1943. Novato, CA: Presidio, 1983. ISBN 0-89141-196-8 OCLC 9945654 Burriss, T. Moffatt. Strike and Hold: A Memoir of the 82nd Airborne in World War II. Washington, D.C.: Brassey's, 2000. ISBN 1-57488-258-9 OCLC 43903491 Caraccilo, Dominic J. The Ready Brigade of the 82nd Airborne in Desert Storm: A Combat Memoir by the Headquarters Company Commander. Jefferson, N.C.: McFarland, 1993. ISBN 0-89950-829-4 OCLC 27265069 Carter, Ross S. Those Devils in Baggy Pants. Cutchogue, NY: Buccaneer Books, 1996.
Legal proceedings involving UCC, the United States and Indian governments, local Bhopal authorities, and the disaster victims started immediately after the catastrophe. The Indian Government passed the Bhopal Gas Leak Act in March 1985, allowing the Government of India to act as the legal representative for victims of the disaster, leading to the beginning of legal proceedings. Initial lawsuits were generated in the United States federal court system. On 17 April 1985, Federal District court judge John F. Keenan (overseeing one lawsuit) suggested that "'fundamental human decency' required Union Carbide to provide between $5 million and $10 million to immediately help the injured" and suggested the money could be quickly distributed through the International Red Cross. UCC, on the notion that doing so did not constitute an admission of liability and the figure could be credited toward any future settlement or judgement, offered a $5 million relief fund two days later. The Indian government turned down the offer. In March 1986, UCC proposed a settlement figure, endorsed by plaintiffs' U.S. attorneys, of $350 million that would, according to the company, "generate a fund for Bhopal victims of between $500–600 million over 20 years". In May, litigation was transferred from the United States to Indian courts by a U.S. District Court ruling. Following an appeal of this decision, the U.S. Court of Appeals affirmed the transfer in November 1986, judging that UCIL was a "a separate and independent legal entity, managed and operated exclusively by Indian citizens in India".
Prokaryotes: 50S ribosomal subunit, 23S rRNA Eukaryotes: 60S ribosomal subunit, 28S rRNA See also: Ribosomal RNA § Subunits and associated ribosomal RNA, mitochondrial ribosome, and Chloroplast § Chloroplast ribosomes. Peptidyl transferases are not limited to translation, but there are relatively few enzymes with this function.
The first mountain-building tectonic plate collision that initiated the construction of what are today the Appalachians occurred at least a billion years ago when the pre-North American craton called Laurentia collided with at least one other craton — Amazonia. All the other cratons of the earth also collided at about this time to form the supercontinent Rodinia and were surrounded by one single ocean. (It is possible that the cratons of Kalahari, and Rio Plato, were also part of that early collision since they were present as Rodinia broke up). Mountain-building referred to as the Grenville Orogeny occurred along the boundaries of the cratons. The present Appalachian Mountains have at least two areas which are made from rock formations that were formed during this orogeny - the Blue Ridge Mountains and the Adirondacks.
== Passport power == The Henley Passport Index 2019 measures how many nations a given passport can enter without a visa. It ranks 190 nations on the "strength" of its passport. Thailand was ranked 68 of 190 countries (1=strong passport; 190=weak passport). A Thai passport can gain entry to 75 nations visa free. Other ASEAN nations ranked were: Singapore, 2/189 countries visa-free; Malaysia, 12/179; Brunei, 21/165; Indonesia, 72/71; Philippines, 74/66; Cambodia, 84/54; Laos, 86/52; Vietnam, 87/51; Myanmar, 90/48. Arton Capital's Passport Index 2017 ranks 193 member nations of the UN, as well as six territories, a total of 199 passport-issuing entities, on the number of countries a given passport can enter either visa-free (VF) or with a visa on arrival (VOA). Thailand ranked 107th of 199 nations in the number of VF/VOA countries granting its citizens visa-less entry (1=most passport power; 199=least passport power). Other ASEAN nations ranked were Singapore, 3; Malaysia, 19; Brunei, 49; Philippines, 127; Indonesia, 137; Cambodia, 154; Vietnam, 159; Laos, 169; and Myanmar, 180. The Passport Index also ranks countries by the number of countries to which they extend VF or VOA visas, a "Welcoming Index". Thailand ranked 62nd of 104 nations (due to numerous ties) (1=most countries granted VF or VOA entry; 104=fewest countries granted VF or VOA entry). Other ASEAN nations ranked were Cambodia, 1; Laos, 15; Indonesia, 16; Malaysia, 17; Singapore, 18; Philippines, 19; Brunei, 70; Vietnam, 83; Myanmar, 96.
Sources: en.wikipedia.org
Enzyme replacement therapy Certain lysosomal storage diseases are treated with infusions of a recombinant enzyme (produced in a laboratory), which can reduce the accumulation of the compounds in various tissues. Examples include Gaucher disease, Fabry disease, Mucopolysaccharidoses and Glycogen storage disease type II. Such treatments are limited by the ability of the enzyme to reach the affected areas (the blood brain barrier prevents enzyme from reaching the brain, for example), and can sometimes be associated with allergic reactions. The long-term clinical effectiveness of enzyme replacement therapies vary widely among different disorders.
== Historical references == Curtius, Th. (1890). "Ueber Stickstoffwasserstoffsäure (Azoimid) N3H". Ber. (in German). 23 (2): 3023–3033. doi:10.1002/cber.189002302232. Curtius, Th. (1894). "20. Hydrazide und Azide organischer Säuren I. Abhandlung". J. Prakt. Chem. (in German). 50 (1): 275–294. doi:10.1002/prac.18940500125. Darapsky, August (1936). "Darstellung von α-Aminosäuren aus Alkyl-cyanessigsäuren". J. Prakt. Chem. (in German). 146 (8–12): 250–267. doi:10.1002/prac.19361460806. Darapsky, August; Hillers, Dietrich (1915). "Über das Hydrazid der Cyanessigsäure, Isonitrosocyanessigsäure und Nitrocyanessigsäure". J. Prakt. Chem. (in German). 92 (1): 297–341. doi:10.1002/prac.19150920117.
=== Geriatrics === Most antidepressants, including SNRIs, are safe and effective in the geriatric population. The geriatric population is at greater risk for adverse effects relating to drug interaction as they are more likely to experience polypharmacy. Decisions are often based on co-morbid conditions, drug interactions, and patient tolerance. Due to differences in body composition and metabolism, starting doses are often half that of the recommended dose for younger adults. Studies show that these factors also put the geriatric population at increased risk of adverse effects when treated with SNRIs but not with SSRIs.
Direct vs Indirect link PKPD models Direct vs Indirect response PKPD models Time variant vs time invariant Cell lifespan models Complex response models PKPD modeling has its importance at each step of the drug development and it has shown its usefulness in many diseases. The Food and Drug Administration also provides guidances for Industry to recommend how exposure-response studies should be performed.
Sources: en.wikipedia.org
Chromatography reports how much material elutes as a single peak but does not confirm what that material is. Mass spectrometry supplies the molecular mass, which is characteristic of a given sequence and its modifications. Together the two methods support both a purity figure and an identity claim.
Hydrolysis, oxidation of susceptible residues, and aggregation all contribute, and their rates depend on pH, temperature, and concentration. Dissolved oxygen and trace metal ions accelerate oxidation. Keeping solutions cold, dilute, and free of unnecessary handling reduces these pathways.
Not always, because the value depends on the detection wavelength, the gradient, and how peak areas are integrated. A figure of ninety-eight percent from one laboratory may not mean the same as the same number from another. Comparing full chromatograms and mass spectra is more informative than comparing a single number.
It is a synthetic peptide modeled on growth hormone-releasing hormone. The molecule is used in research on pituitary growth hormone secretion. It differs from the natural hormone through several stabilizing substitutions.